GNOM

Global X Genomics & Biotechnology ETF
*Unless otherwise stated, data provided by FactSet.

GNOM Fund Description

GNOM tracks a market-cap selected and weighted index of global biotech equities.

GNOM Factset Analytics Insight

As the name states, GNOM is Global X’s take on biotech, with more of an emphasis on genomics specifically. The fund fleshes out its description of this sector by including companies deriving more than 50% of their revenues from the following 5 business activities: (i) gene editing, (ii) genomic sequencing, (iii) development and testing of genetic medicine/therapies, (iv) computational genomics and genetic diagnostics, and/or (v) biotechnology. The index may include either small- and mid-cap companies, and included constituents are market-cap weighted.

GNOM MSCI ESG Analytics Insight

Global X Genomics & Biotechnology ETF has an MSCI ESG Fund Rating of BB based on a score of 3.38 out of 10. The MSCI ESG Fund Rating measures the resiliency of portfolios to long-term risks and opportunities arising from environmental, social, and governance factors. ESG Fund Ratings range from best (AAA) to worst (CCC). Highly rated funds consist of companies that tend to show strong and/or improving management of financially relevant environmental, social and governance issues. These companies may be more resilient to disruptions arising from ESG events.

The fund’s Peer Rank reflects the ranking of a fund’s MSCI ESG Fund Quality Score against the scores of other funds within the same peer group, as defined by the Thomson Reuters Lipper Global Classification. Global X Genomics & Biotechnology ETF ranks in the 12nd percentile within its peer group and in the 21st percentile within the global universe of all funds covered by MSCI ESG Fund Ratings.

GNOM Charts And Performance

Price Chart ($)
Total Return Chart (%)
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
  • 1 Month
  • 3 Months
  • YTD
  • 1 Year
  • 3 Years
  • 5 Years
  • Max
Compare
Reset
Select ETFs to compare their performance:
PERFORMANCE [as of 07/09/20] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS
GNOM 11.85% 40.62% 20.31% 25.71% -- -- --
ticker (NAV) 12.02% 40.30% 20.22% 25.45% -- -- --
Solactive Genomics Index -- -- -- -- -- -- --
Thomson Reuters Global Biotechnology & Medical Research -- -- -- -- -- -- --
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

GNOM Summary Data

Mirae Asset
Global X
04/05/19
Open-Ended Fund
0.68%
$46.84M
$398.50K
0.67%
BBH

GNOM Portfolio Data

$10.40B
-16.07
5.56
--
12/30/20
41

GNOM Index Data

Solactive Genomics Index
Market Cap
Market Cap
Thomson Reuters Global Biotechnology & Medical Research

GNOM Portfolio Management

0.68%
--
--
--

GNOM Tax Exposures

20.00% / 39.60%
--
Qualified dividends
No

GNOM Fund Structure

Open-Ended Fund
No
No
100% / 0%
N/A
N/A
Medium
Daily
Cboe Book Viewer
Top Of Book
Last 10 Trades
Bats BZX Real-time Quote -

GNOM Factset Analytics Block Liquidity

As of 07/10/20
5
4
3
2
1

This measurement shows how easy it is to trade a $1 million USD block of GNOM. GNOM is rated a N/A out of 5.

GNOM Tradability

23,963
$398.50K
18,358
$305.89K
0.67%
$0.12
0.14%
4.32% / -2.18%
None
--
50,000
0.37
--
--
0
$18.73
N/A

GNOM Sector/Industry Breakdown


GNOM
Segment Benchmark
76.90%
100.00%
19.06%
--
4.04%
--

GNOM Top 10 Holdings[View All]

5.76%
5.54%
4.59%
4.24%
4.21%
4.21%
3.77%
3.70%
3.69%
3.68%
43.39%

GNOM Countries


GNOM
Segment Benchmark
94.16%
76.59%
3.81%
2.39%
2.03%
1.68%
--
0.44%
--
1.04%
--
0.02%
--
0.92%
--
1.29%
--
0.39%
--
0.21%

GNOM Regions


GNOM
Segment Benchmark
94.16%
76.85%
5.84%
9.43%
--
13.72%

GNOM Economic Development


GNOM
Segment Benchmark
100.00%
99.26%
--
0.74%

GNOM Performance Statistics

0.86
1.32
1.07
1.42
1.15%
Thomson Reuters Global Biotechnology & Medical Research

GNOM MSCI ESG Ratings

3.38 / 10
20.88
12.49
--
27.72%
29.08

GNOM Benchmark Comparison Holdings

41
223
30
11.84%

GNOM Benchmark Comparison Summary


GNOM
Segment Benchmark
41
223
$10.40B
$31.79B
-16.07
-73.68
5.56
6.18
0.11%
0.51%
Medium
Medium

GNOM Benchmark Comparison Market Cap Size


GNOM
Segment Benchmark
19.03%
55.97%
47.97%
29.76%
30.53%
12.23%
2.47%
2.04%